Departments, Centers, & Programs:
Massachusetts Eye and Ear Infirmary
243 Charles Street
Boston, MA 02114 - 3002
- MD, Georgetown University School of Medicine
- MD, Massachusetts Eye & Ear Infirmary
- MD, RHODE ISLAND HOSPITAL
- Residency, Albany Medical Center
- Fellowship, Mass Eye and Ear Infirmary
- Fellowship, Massachusetts Eye & Ear
- Fellowship, Massachusetts Eye and Ear Infirmary
American Board Certifications
- Ophthalmology, American Board of Ophthalmology
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Ciolino is a clinician scientist who specializes in the diagnosis and treatment of corneal diseases. His research aims to develop and test a drug-eluting contact lens for the treatment of eye diseases. Specifically, he plans to carry out proof-of-concept studies to demonstrate the functionality and safety of this drug-eluting contact lens, advancing toward the goal of treating glaucoma, eye infections, and ocular inflammation in patients. He is currently working to bring a dexamethasone-eluting contact lens and a latanoprost-eluting contact lens closer to first tests in human subjects.
1. Coco G, Kheirkhah A, Foulsham W, Dana R, Ciolino JB. Keratoconus progression associated with hormone replacement therapy. Am J Ophthalmol Case Rep. 2019 Sep; 15:100519.
2. Ross AE, Bengani LC, Tulsan R, Maidana DE, Salvador-Culla B, Kobashi H, Kolovou PE, Zhai H, Taghizadeh K, Kuang L, Mehta M, Vavvas DG, Kohane DS, Ciolino JB. Topical sustained drug delivery to the retina with a drug-eluting contact lens. Biomaterials. 2019 Oct; 217:119285.
3. Coco G, Amparo F, Patel SP, Foulsham W, Carreno-Galeano JT, Stockslager SG, Ciolino JB, Yin J, Dana R. Oral guaifenesin for treatment of filamentary keratitis: A pilot study. Ocul Surf. 2019 Jul; 17(3):565-570.
4. Wirta DL, Torkildsen GL, Moreira HR, Lonsdale JD, Ciolino JB, Jentsch G, Beckert M, Ousler GW, Steven P, Krösser S. A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease. Ophthalmology. 2019 Jun; 126(6):792-800.
5. Kobashi H, Ciolino JB. Innovative Development of Contact Lenses. Cornea. 2018 Nov; 37 Suppl 1:S94-S98.